Danny Beales

It is an honour to serve under your chairmanship, Mr Turner, and I thank my hon. Friend the Member for North Warwickshire and Bedworth (Rachel Taylor) for bringing us this debate. I am proud to call her a colleague and a friend. She is an exemplary part of the LGBT movement, and I am proud to associate myself with her and her comments in this debate. We have heard already about the extraordinary length of waiting lists for gender-affirming care. Based on current appointment rates, a trans person can expect to wait an average of 25 years across the UK for an initial appointment to start gender-affirming care. That is simply not good enough, and we would never accept this in any other patient category in our NHS. We have heard much in this debate about the delays in receiving this care and the devastating impact that has on the lives of transgender people. With that in mind, I would like to ask the Minister whether waiting times for transgender patients are included within the current target to cut waiting times to 18 weeks by the end of this Parliament. Can she commit specifically to decreasing the length of waiting times for gender care by the end of the Parliament? The second issue that I want to raise—which we have heard about already—is the operation of NHS gender care services more generally, and shared care as an important component of them. Once a gender clinic deems a trans person’s medical transition complete, it discharges them from its care to that of the GP, who will then authorise hormone prescriptions and contact the clinic about any issues. However, GPs in my constituency —and many that we have heard about in this debate—are increasingly refusing to enter into shared care agreements. The rate of such rejections has gone up from 5% to 21% in the last 12 months. Will the Minister therefore commit to clarifying the roles and responsibilities of different NHS services for the provision of gender-related healthcare? It is unacceptable that those who have waited years or decades for initial appointments, who have jumped through all the hoops possible to get NHS gender care, and who are finally in receipt of NHS prescriptions from NHS doctors, are then in practice unable to receive a prescription because their GP has unilaterally decided not to perform blood monitoring tests and provide that shared care support. It is vital, as has been said, that we ensure access to a range of health services beyond gender-specific needs, whether sexual health services, reproductive health services, or primary and secondary care more generally. The voluntary and community sector, including trans-specific groups, perform a vital role in providing services, brokerage, networking and support in the health service but they are often poorly funded. I encourage the Minister to see what the NHS can do to support trans-led health organisations within it. Unfortunately and increasingly, a hostile environment is being developed across much of the media. It seeks to erase the existence of trans people from our past, present and future. It is vital that we speak up about their existence, and about the experience of our constituents. I have been contacted by many of my constituents who are trans to detail the impact that the media, political and public discourse is having on their lives. I welcome this debate as part of resetting that discourse in this place and in our society. Fundamentally, this is about treating all people with dignity and respect, and about recognising that trans people exist, as do their health needs.